Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence

Glioblastoma multiforme (GBM), a malignant brain tumor with a dismal prognosis, shows a high level of chemo- and radioresistance and, therefore, attempts to sensitize glioma cells are highly desired. Here, we addressed the question of whether artesunate (ART), a drug currently used in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Berte, Nancy, Lokan, Stefanie, Eich, Marcus, Kim, Ella, Kaina, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341871/
https://www.ncbi.nlm.nih.gov/pubmed/27626497
http://dx.doi.org/10.18632/oncotarget.11972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341871/
https://www.ncbi.nlm.nih.gov/pubmed/27626497
http://dx.doi.org/10.18632/oncotarget.11972

Ejemplares similares